Page 5 - Nasdaq Bmea News Today

Biomea Fusion (NASDAQ:BMEA – Get Rating) had its price objective decreased by Citigroup from $60.00 to $55.00 in a research report sent to investors on Friday morning, The Fly reports. Several other analysts also recently weighed in on the company. Keefe, Bruyette & Woods restated a buy rating and set a $22.00 target price on […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating)’s share price traded down 3.8% during mid-day trading on Monday after Citigroup lowered their price target on the stock from $60.00 to $55.00. The stock traded as low as $24.85 and last traded at $25.01. 514,627 shares were traded during mid-day trading, a decline of 19% from the […]

Biomea Fusion (NASDAQ:BMEA – Get Rating) had its price objective reduced by analysts at Citigroup from $60.00 to $55.00 in a note issued to investors on Friday, The Fly reports. Citigroup’s price target points to a potential upside of 111.54% from the stock’s previous close. Other equities research analysts have also recently issued research reports […]

Biomea Fusion (NASDAQ:BMEA – Get Rating)‘s stock had its “buy” rating reissued by equities researchers at EF Hutton Acquisition Co. I in a research note issued to investors on Thursday, Benzinga reports. They currently have a $33.00 target price on the stock. EF Hutton Acquisition Co. I’s price target would indicate a potential upside of […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) Director Bihua Chen purchased 400,000 shares of the stock in a transaction that occurred on Thursday, March 30th. The stock was bought at an average price of $30.00 per share, with a total value of $12,000,000.00. Following the completion of the acquisition, the director now owns 3,570,872 shares […]

Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price lifted by Oppenheimer from $25.00 to $47.00 in a report published on Wednesday morning, The Fly reports. Oppenheimer currently has an outperform rating on the stock. A number of other analysts also recently weighed in on BMEA. HC Wainwright boosted their target price on Biomea […]

Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price lifted by Piper Sandler from $16.00 to $40.00 in a report released on Tuesday morning, The Fly reports. They currently have an overweight rating on the stock. Several other research analysts have also recently weighed in on the company. Citigroup began coverage on Biomea Fusion […]

Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price upped by Citigroup from $20.00 to $60.00 in a research note published on Wednesday morning, The Fly reports. The firm currently has a buy rating on the stock. BMEA has been the subject of several other research reports. HC Wainwright upped their price objective on […]

Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price raised by Piper Sandler from $16.00 to $40.00 in a report published on Tuesday morning, The Fly reports. Piper Sandler currently has an overweight rating on the stock. BMEA has been the topic of several other research reports. HC Wainwright reissued a buy rating and […]

REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company...